Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1989;13:690-695

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eliades, D.
Right arrow Articles by Haddy, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eliades, D.
Right arrow Articles by Haddy, F.

Hypertension, Vol 13, 690-695, Copyright © 1989 by American Heart Association


ARTICLES

Hemodynamic effects of bufalin in the anesthetized dog

D Eliades, B Swindall, J Johnston, M Pamnani and F Haddy
Department of Physiology, Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814-4799.

Studies in Lichstein's laboratory suggest that the endogenous digitalislike substance implicated in low renin hypertension might be a steroidal dienolide derivative. If this is true, the bufadienolides should block potassium vasodilation and enhance norepinephrine vasoconstriction, constrict blood vessels, raise blood pressure, and produce natriuresis and diuresis. We have therefore examined these parameters while infusing bufalin (aglycone), a bufadienolide, intrabrachially and intravenously in the anesthetized dog. Intrabrachial infusion of 5-25 micrograms/min with brachial arterial blood flow held constant at 100 ml/min produced a dose-dependent increase in perfusion pressure with rapid onset and offset, a progressive decrease in the vasodilator response to intrabrachial injection of 1 ml iso-osmotic potassium chloride solution (but not to acetylcholine), and an increase in the vasoconstrictor response to intrabrachial injection of 0.1 microgram norepinephrine. Intravenous infusion at 5-50 micrograms/min produced a dose-dependent increase in systemic arterial blood pressure, rate of change of ventricular pressure (dP/dt), and after the highest dose, cardiac irregularities. Natriuresis and diuresis were not observed. Thus, bufalin does in fact have some of the physiological properties required to be considered a candidate for the digitalislike substance found in low renin hypertension.


This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S.-W. Wang, Y.-C. Chiao, S.-C. Tsai, C.-C. Lu, J.-J. Chen, H.-C. Shih, Y.-H. Chen, H. Lin, C.-M. Hwu, and P. S. Wang
Inhibition of Bufalin on Pituitary and Testicular Function in Rats
J. Pharmacol. Exp. Ther., November 1, 1997; 283(2): 528 - 532.
[Abstract] [Full Text]


Home page
HypertensionHome page
B. Sich, U. Kirch, M. Tepel, W. Zidek, and W. Schoner
Pulse Pressure Correlates in Humans With a Proscillaridin A Immunoreactive Compound
Hypertension, May 1, 1996; 27(5): 1073 - 1078.
[Abstract] [Full Text]


Home page
HypertensionHome page
A. R. Patel, T. Kurashina, J. P. Granger, and K. A. Kirchner
Acute Na+,K+-ATPase Inhibition With Bufalin Impairs Pressure Natriuresis in the Rat
Hypertension, March 1, 1996; 27(3): 668 - 671.
[Abstract] [Full Text]